Theseus Pharmaceuticals Inc
NASDAQ:THRX
Cash Flow Statement
Cash Flow Statement
Theseus Pharmaceuticals Inc
Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||
Net Income |
(16)
|
(16)
|
(22)
|
(27)
|
(33)
|
(38)
|
(46)
|
(51)
|
(55)
|
(58)
|
(57)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Stock-Based Compensation |
2
|
3
|
4
|
4
|
6
|
7
|
11
|
11
|
12
|
13
|
0
|
|
Other Non-Cash Items |
7
|
2
|
4
|
4
|
6
|
7
|
11
|
11
|
12
|
12
|
9
|
|
Change in Working Capital |
(0)
|
(1)
|
(1)
|
(4)
|
(2)
|
(0)
|
2
|
7
|
(1)
|
0
|
(2)
|
|
Cash from Operating Activities |
(10)
N/A
|
(14)
-44%
|
(19)
-28%
|
(27)
-47%
|
(30)
-9%
|
(31)
-5%
|
(33)
-6%
|
(33)
0%
|
(44)
-33%
|
(46)
-4%
|
(50)
-8%
|
|
Investing Cash Flow | ||||||||||||
Capital Expenditures |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Items |
0
|
0
|
0
|
0
|
(91)
|
(93)
|
(106)
|
(117)
|
(42)
|
(91)
|
(69)
|
|
Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(91)
N/A
|
(94)
-3%
|
(106)
-13%
|
(117)
-10%
|
(42)
+64%
|
(91)
-115%
|
(69)
+25%
|
|
Financing Cash Flow | ||||||||||||
Net Issuance of Common Stock |
112
|
110
|
105
|
268
|
168
|
166
|
166
|
0
|
50
|
50
|
50
|
|
Other |
0
|
(0)
|
(2)
|
(4)
|
0
|
(4)
|
(2)
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
112
N/A
|
110
-2%
|
104
-6%
|
264
+155%
|
164
-38%
|
163
-1%
|
164
+1%
|
0
-100%
|
50
+27 494%
|
50
+0%
|
50
N/A
|
|
Change in Cash | ||||||||||||
Net Change in Cash |
102
N/A
|
96
-6%
|
85
-11%
|
237
+178%
|
44
-82%
|
38
-13%
|
25
-34%
|
(150)
N/A
|
(37)
+76%
|
(87)
-138%
|
(69)
+21%
|
|
Free Cash Flow | ||||||||||||
Free Cash Flow |
(10)
N/A
|
(14)
-44%
|
(19)
-28%
|
(27)
-47%
|
(30)
-9%
|
(31)
-6%
|
(33)
-6%
|
(33)
0%
|
(44)
-33%
|
(46)
-4%
|
(50)
-8%
|